genOway designs genetically modified mouse, rat, and cell line models of the highest physiological relevancy for bio-pharmaceutical and academic researchers in:
of the Top 20
A catalog of reliable and efficient translational mouse models for immunotherapy expressing humanized immune checkpoints.
Immunodeficient mice displaying functional human lymphoid and myeloid compartments without graft versus host disease and other side effects.
A double-humanized serum albumin/neonatal Fc receptor mouse model that maintains an autologous receptor-ligand interaction to assess PK/PD studies.
"We were highly impressed by the expert manner in which genOway’s scientists managed what I felt to be a rather..."
Prof. Simon C. ROBSON
Director at Beth Israel Deaconess Medical Center> read full testimonial
"For Sensei Biotherapeutics, obtaining clinical trial approval (IND) for our anti-VISTA SNS-101 antibody represents a..."
Edward van der Horst, Ph.D.
Chief Scientific Officer at Sensei Biotherapeutics> read full testimonial
"We have worked with genOway in different projects for several years, and we are very impressed by their competence,..."
Prof. Maria T. DIAZ-MECO
Lab Head at Sanford Burnham Prebys Medical Discovery Institute> read full testimonial
"genOway is the Mercedes Benz of transgenic outsourcing companies."
Prof. Robert TERKELTAUB
Director at UC San Diego School of Medicine> read full testimonial
"I am truly impressed with the responsiveness and help that I have obtained from genOway. It has been a pleasure to work..."
Prof. Bellur S. PRABHAKAR
Associate Dean at University of Illinois College of Medicine> read full testimonial
"Receiving the FDA “Study May Proceed” for our CRD3874, an IV-administered STING agonist, represents a key milestone..."
CEO & CSO at Curadev Pharma> read full testimonial
"genOway has really impressed me with the quality of its service and its competence. I would emphasize their reliability..."
Prof. Ruben PIO
Director at CIMA, University of Navarra> read full testimonial
"Without you it would have been impossible for us to establish this transgenic mouse from the EUCOMM ES cells. I was most..."
Dr. Matthias HUNDT
Instructor at La Jolla Institute for Allergy & Immunology> read full testimonial
"Leader for the development of transgenic mice and rats, genOway is a very reliable biotechnology company. Their main..."
Prof. Shomi BHATTACHARYA
Director of Cabimer> read full testimonial
"I have never witnessed such proactive behavior with customers. genOway truly understand our challenges and is equipped..."
Dr. Carla BOCCACCIO
University of Torino Medical School> read full testimonial
"genOway has carried out several projects for us. This collaboration has been very successful. Not just because we have..."
Prof. Arne KLUNGLAND
Lab Head at Oslo University Hospital> read full testimonial
"With the idea to develop a mouse model for the rare human disease ALD, we reached out to genOway to help us in finding..."
Dr. Stephan KEMP
Associate Professor at Academic Medical Center (AMC)> read full testimonial
"genOway is a very reliable company. They provide a very flexible service customized to our needs and expectation. I..."
Dr. Angela GRECO
Director at IRCCS Foundation Milan> read full testimonial
"genOway is a leading company in the field of genetically modified mouse and rat models. Its technology platform is..."
Prof. Pier Paolo DI FIORE
IFOM-IEO Campus, University of Milan> read full testimonial
"IEO and genOway collaboration started some years ago while we were looking for collaborative and highly professional..."
Prof. Pier Giuseppe PELICCI
Scientific Director of the European Institute of Oncology Milan> read full testimonial
"We are actively engaged in the production of a number of knock-in mouse models with genOway. We have been very pleased..."
Prof. Stephen MOSS
Chair of Biomedical Research at University College London> read full testimonial
"Collaboration with genOway’s team has been fruitful: We have been able to work with them, especially with their..."
Company President and Scientific Director at Ambiotis> read full testimonial
"genOway's technology is excellent and their mouse business is impressive. We are looking forward to working..."
Dr. Ulrich THIBAUT
Supervisory Board of Glycotope GmbH Berlin> read full testimonial
"I ascertain that genOway has provided extremely efficient and competent services to us and we will very likely use them..."
Prof. Ludwig NEYSES
Chair of Medicine at University of Manchester> read full testimonial
"genOway has not only successful provided this service, but we have benefited a great deal from their consultation,..."
Dr. Paul RILEY
Chair of Development and Cell Biology at Oxford University> read full testimonial
Designed to specifically address your research project with the support and advice of our scientific team.
Humanized, Knockout and reporter immune checkpoint cell lines for tumor-growth essays, syngeneic models, and in-vitro mechanistic studies.
Physiologically relevant models to assess and evaluate T-cell engagement efficacy for innovative therapeutics in cancer immunotherapies.
Looking for an experienced and qualified industrial partner for your EU project?
We have successfully participated in 13 EU programs, and can help you build a robust European research consortium structure.